Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INNO.CN | ||||
| Company | Innocan Pharma Corp | ||||
| Price Information | |||||
| Exchange | CNSX | ||||
| Open | 7.3800 | ||||
| High | 7.3800 | ||||
| Low | 6.9900 | ||||
| Latest | 7.0000 | ||||
| Change | -0.6400 | ||||
| % Change | -8.38% | ||||
| Volume | 900 | ||||
| 20-Day Average Volume | 1,130 | ||||
| Previous Close | 7.6400 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 7.6820 | ||||
| 20-Day Raw Stochastic | 17.89% | ||||
| 20-Day Relative Strength | 31.50 | ||||
| Weighted Alpha | -59.08 | ||||
| Today's Opinion | 88% Sell | ||||
| Previous Opinion | 88% Sell | ||||
| Last Month's Opinion | 40% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.58% since 01/14/26 | ||||
| Low | 6.9900 on 01/22/26 | ||||
| High | 8.3000 on 01/20/26 | ||||
| 1-Month | |||||
| %Chg | -6.67% since 12/19/25 | ||||
| Low | 6.6600 on 12/30/25 | ||||
| High | 8.5600 on 01/12/26 | ||||
| 3-Month | |||||
| %Chg | -56.25% since 10/22/25 | ||||
| Low | 6.6600 on 12/30/25 | ||||
| High | 19.1500 on 11/04/25 | ||||
| 6-Month | |||||
| %Chg | -48.72% since 07/22/25 | ||||
| Low | 6.6600 on 12/30/25 | ||||
| High | 21.0000 on 10/06/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 34,371 | ||||
| Shares Outstanding, K | 4,499 | ||||
| Annual Sales | 29,437,000 | ||||
| Annual Net Income | -1,834,000 | ||||
| Last Quarter Sales | 6,822,000 | ||||
| Last Quarter Net Income | -1,947,000 | ||||
| 60-Month Beta | 0.20 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 11/26/25 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||